SYF-PA

SYF-PA
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.834B ▲ | $1.248B ▲ | $1.077B ▲ | 22.28% ▲ | $2.89 ▲ | $1.557B ▲ |
| Q2-2025 | $4.712B ▼ | $1.245B ▲ | $967M ▲ | 20.522% ▲ | $2.51 ▲ | $1.378B ▲ |
| Q1-2025 | $4.804B ▼ | $1.243B ▼ | $757M ▼ | 15.758% ▲ | $1.91 ▼ | $1.109B ▲ |
| Q4-2024 | $4.919B ▼ | $1.267B ▲ | $774M ▼ | 15.735% ▼ | $1.93 ▼ | $1.093B ▼ |
| Q3-2024 | $4.99B | $1.189B | $789M | 15.812% | $1.96 | $1.149B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $18.961B ▼ | $116.984B ▼ | $99.919B ▼ | $17.065B ▲ |
| Q2-2025 | $22.362B ▼ | $120.505B ▼ | $103.553B ▼ | $16.952B ▲ |
| Q1-2025 | $24.353B ▲ | $122.026B ▲ | $105.445B ▲ | $16.581B ▲ |
| Q4-2024 | $17.79B ▼ | $119.463B ▲ | $102.883B ▼ | $16.58B ▲ |
| Q3-2024 | $20.279B | $119.229B | $103.249B | $15.98B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.077B ▲ | $2.637B ▲ | $-1.574B ▲ | $-4.955B ▼ | $-3.892B ▼ | $2.637B ▲ |
| Q2-2025 | $967M ▲ | $2.56B ▲ | $-2.241B ▼ | $-2.817B ▼ | $-2.498B ▼ | $2.56B ▲ |
| Q1-2025 | $757M ▼ | $2.2B ▼ | $3.603B ▲ | $2.119B ▲ | $7.922B ▲ | $2.2B ▼ |
| Q4-2024 | $774M ▼ | $2.353B ▼ | $-4.963B ▼ | $-617M ▲ | $-3.226B ▼ | $2.353B ▼ |
| Q3-2024 | $789M | $2.763B | $-2.231B | $-1.231B | $-699M | $2.763B |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Putting it together, Synchrony combines solid profitability, strong cash generation, and a strengthening capital base with a clear technology‑driven strategy. The business is well entrenched with major partners and has broadened beyond traditional store cards into healthcare and point‑of‑sale financing, which can support growth and diversification. At the same time, results will remain sensitive to the credit cycle, consumer health, regulation, and intense competition from both incumbents and fintechs. For holders of securities tied to Synchrony, the key variables to watch are credit performance, funding conditions, and the company’s ability to keep its digital and data capabilities ahead of rivals.
About Synchrony Financial
https://www.synchrony.comSynchrony Financial, together with its subsidiaries, operates as a consumer financial services company in the United States. It provides credit products, such as credit cards, commercial credit products, and consumer installment loans.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.834B ▲ | $1.248B ▲ | $1.077B ▲ | 22.28% ▲ | $2.89 ▲ | $1.557B ▲ |
| Q2-2025 | $4.712B ▼ | $1.245B ▲ | $967M ▲ | 20.522% ▲ | $2.51 ▲ | $1.378B ▲ |
| Q1-2025 | $4.804B ▼ | $1.243B ▼ | $757M ▼ | 15.758% ▲ | $1.91 ▼ | $1.109B ▲ |
| Q4-2024 | $4.919B ▼ | $1.267B ▲ | $774M ▼ | 15.735% ▼ | $1.93 ▼ | $1.093B ▼ |
| Q3-2024 | $4.99B | $1.189B | $789M | 15.812% | $1.96 | $1.149B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $18.961B ▼ | $116.984B ▼ | $99.919B ▼ | $17.065B ▲ |
| Q2-2025 | $22.362B ▼ | $120.505B ▼ | $103.553B ▼ | $16.952B ▲ |
| Q1-2025 | $24.353B ▲ | $122.026B ▲ | $105.445B ▲ | $16.581B ▲ |
| Q4-2024 | $17.79B ▼ | $119.463B ▲ | $102.883B ▼ | $16.58B ▲ |
| Q3-2024 | $20.279B | $119.229B | $103.249B | $15.98B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.077B ▲ | $2.637B ▲ | $-1.574B ▲ | $-4.955B ▼ | $-3.892B ▼ | $2.637B ▲ |
| Q2-2025 | $967M ▲ | $2.56B ▲ | $-2.241B ▼ | $-2.817B ▼ | $-2.498B ▼ | $2.56B ▲ |
| Q1-2025 | $757M ▼ | $2.2B ▼ | $3.603B ▲ | $2.119B ▲ | $7.922B ▲ | $2.2B ▼ |
| Q4-2024 | $774M ▼ | $2.353B ▼ | $-4.963B ▼ | $-617M ▲ | $-3.226B ▼ | $2.353B ▼ |
| Q3-2024 | $789M | $2.763B | $-2.231B | $-1.231B | $-699M | $2.763B |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Putting it together, Synchrony combines solid profitability, strong cash generation, and a strengthening capital base with a clear technology‑driven strategy. The business is well entrenched with major partners and has broadened beyond traditional store cards into healthcare and point‑of‑sale financing, which can support growth and diversification. At the same time, results will remain sensitive to the credit cycle, consumer health, regulation, and intense competition from both incumbents and fintechs. For holders of securities tied to Synchrony, the key variables to watch are credit performance, funding conditions, and the company’s ability to keep its digital and data capabilities ahead of rivals.

CEO
Brian D. Doubles
Compensation Summary
(Year 2015)

CEO
Brian D. Doubles
Compensation Summary
(Year 2015)
Ratings Snapshot
Rating : A+
Institutional Ownership
Summary
Only Showing The Top 1


